Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver
Justin A. Fletcher, … , Shawn C. Burgess, Jeffrey D. Browning
Justin A. Fletcher, … , Shawn C. Burgess, Jeffrey D. Browning
Published April 23, 2019
Citation Information: JCI Insight. 2019;4(11):e127737. https://doi.org/10.1172/jci.insight.127737.
View: Text | PDF
Research Article Hepatology Metabolism

Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver

  • Text
  • PDF
Abstract

Nonalcoholic fatty liver disease (NAFLD) is a highly prevalent, and potentially morbid, disease that affects one-third of the US population. Normal liver safely accommodates lipid excess during fasting or carbohydrate restriction by increasing their oxidation to acetyl-CoA and ketones, yet lipid excess during NAFLD leads to hyperglycemia and, in some, steatohepatitis. To examine potential mechanisms, we studied flux through pathways of hepatic oxidative metabolism and gluconeogenesis using 5 simultaneous stable isotope tracers in ketotic (24-hour-fasted) individuals with a wide range of hepatic triglyceride content levels (0%–52%). Ketogenesis was progressively impaired as hepatic steatosis and glycemia worsened. Conversely, the alternative pathway for acetyl-CoA metabolism, oxidation in the tricarboxylic acid (TCA) cycle, was upregulated in NAFLD as ketone production diminished and positively correlated with rates of gluconeogenesis and plasma glucose concentrations. Increased respiration and energy generation that occurred in liver when β-oxidation and TCA cycle activity were coupled may explain these findings, inasmuch as calculated hepatic oxygen consumption was higher during fatty liver and highly correlated with gluconeogenesis. These findings demonstrate that increased glucose production and hyperglycemia in NAFLD is a consequence not of acetyl-CoA production per se, but rather of how acetyl-CoA is further metabolized in liver.

Authors

Justin A. Fletcher, Stanisław Deja, Santhosh Satapati, Xiaorong Fu, Shawn C. Burgess, Jeffrey D. Browning

×

Figure 4

Increased hepatic glucose production in NAFLD is associated with increased acetyl-CoA oxidation and oxygen consumption.

Options: View larger image (or click on image) Download as PowerPoint
Increased hepatic glucose production in NAFLD is associated with increas...
(A) Fractional glucose production was determined using the 2H2O method. Fractional glycogenolysis (Gly) and gluconeogenesis (GNG) were similar in control (n = 17) and NAFLD (n = 23) subjects at 24-hours of fasting. (B) Infusion of [3,4-13C2]glucose was used to determine EGP. Absolute rates of glycogenolysis, as well as gluconeogenesis from OAA and glycerol, were determined by combining EGP with fractional glucose production data. There was a higher rate of EGP in NAFLD subjects due to an increased rate of gluconeogenesis from OAA. (C) Carbon-13 isotopomer analysis of plasma glucose indicated that total anaplerosis was significantly higher in NAFLD (n = 23) compared with control (n = 15) subjects. (D) TCA cycle turnover was increased among NAFLD subjects compared with controls. (E) Oxaloacetate and its precursors, such as pyruvate, can stimulate TCA cycle activity. Plasma pyruvate concentrations were similar in the 2 groups during H-E clamp and declined in both groups as the fasting duration increased; however, NAFLD subjects had, or tended to have, higher pyruvate concentrations at 12 and 24 hours of fasting, respectively (control: n = 11, NAFLD: n = 9). (F) Estimated β-oxidation did not differ between the groups in aggregate, but tended to be lower among those with higher concentrations of hepatic TG (control: n =15, NAFLD: n = 21). (G) In aggregate, NAFLD subjects had O2 consumption rates that were similar to those of controls. This was due to a variable effect of hepatic TG content, as those with mild to moderate hepatic steatosis tended to have higher V̇O2 than controls. (H) NAFLD subjects consumed ≈30% more O2 for each acetyl-CoA produced. Glucose isotopic data was unavailable for 2 control subjects. Combined isotopic data were unavailable for 2 control and 2 NAFLD subjects. Significance was determined using 2-tailed Student’s t test for unpaired data, 1-way ANOVA, and 2-way repeated-measures ANOVA when appropriate.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts